Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis

Annals of Vascular Surgery

Volumn 35, Issue , 2016, Pages 210-225

  Serra, Raffaele ^a   Butrico, Lucia ^a   Fugetto, Francesco ^b   Chibireva, Mariia Dmitrievna ^c   Malva, Alberto ^b   De Caridi, Giovanni ^d   Massara, Mafalda ^d   Barbetta, Andrea ^a   Cannistrà, Marco ^e   de Franciscis, Stefano ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF MESSINA   (Italy)

^e Annunziata Cosenza Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ANGIOGRAPHY; AORTA ARCH SYNDROME; BIOPSY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; ECHOGRAPHY; ENDOVASCULAR SURGERY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNITY; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; MEDLINE; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCOPUS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TISSUES; ADULT; FEMALE; MALE; PREDICTIVE VALUE; RISK FACTOR; TAKAYASU ARTERITIS; TREATMENT OUTCOME;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TAKAYASU ARTERITIS; TREATMENT OUTCOME;

EID: 84992383195     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2016.02.011     Document Type: Review

References (173)

1. 1 Carlson, J.A., The histological assessment of cutaneous vasculitis. Histopathology 56 (2010), 3–23.
2. 2 Lazzarin, P., Pasero, G., Marson, P., et al. Takayasu's arteritis. A concise review and some observations on a putative case reported by Giovanni Battista Morgagni (1761). Reumatismo 57 (2005), 305–313.
3. 3 Jennette, J.C., Falk, R.J., Bacon, P.A., et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 (2013), 1–11.
4. 4 Richards, B.L., March, L., Gabriel, S.E., Epidemiology of large-vessel vasculidities. Best Pract Res Clin Rheumatol 24 (2010), 871–883.
5. 5 Johnston, S.L., Lock, R.J., Gompels, M.M., Takayasu arteritis: a review. J Clin Pathol 55 (2002), 481–486.
6. 6 Kerr, G.S., Hallahan, C.W., Giordano, J., et al. Takayasu arteritis. Ann Intern Med 120 (1994), 919–929.
7. 7 Ladhani, S., Tulloh, R., Anderson, D., Takayasu disease masquarading as interruption of the aortic arch in a 2 year old child. Cardiol Young 11 (2001), 244–246.
8. 8 Mitchell, C.S., Parisi, M.T., Magnetic resonance imaging of Takayasu's aortitis in an infant. J Am Osteopath Assoc 97 (1997), 607–609.
9. 9 Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269 W64.
10. 10 Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52 (1998), 377–384.
11. 11 National Collaborating Centre for Methods and Tools. Quality Checklist for Health Care Intervention Studies. 2008, McMaster University, Hamilton, ON (Updated 01 June, 2010). Retrieved from http://www.nccmt.ca/resources/search/9 Accessed January 15 2016.
12. 12 Amano, J., Suzuki, A., Coronary artery involvement in Takayasu's arteritis. Collective review and guideline for surgical treatment. J Thorac Cardiovasc Surg 102 (1991), 554–560.
13. 13 Park, S.H., Chung, J.W., Lee, J.W., et al. Carotid artery involvement in Takayasu's arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20 (2001), 371–378.
14. 14 Hall, S., Barr, W., Lie, J.T., et al. Takayasu arteritis: A study of 32 North American patients. Medicine (Baltimore) 64 (1985), 89–99.
15. 15 Kinare, S.G., Gandhi, M.A., Deshpande, J.R., Non-specific aortoarteritis (Pathology and Radiology). 1998, Quest Publications, Mumbai.
16. 16 Vaideeswar, P., Deshpande, J.R., Pathology of Takayasu arteritis: A brief review. Ann Pediatr Cardiol 6 (2013), 52–58.
17. 17 Gravanis, M.B., Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol 75 (2000), S21–S33.
18. 18 Vaideeswar, P., Syphilitic aortitis: rearing of the ugly head. Indian J Pathol Microbiol 53 (2010), 624–627.
19. 19 Hotchi, M., Pathological studies on Takayasu arteritis. Heart Vessels 7 (1992), 11–17.
20. 20 Gulati, A., Bagga, A., Large vessel vasculitis. Pediatr Nephrol 25 (2010), 1037–1048.
21. 21 Lie, J.T., Isolated pulmonary Takayasu arteritis: clinicopathologic characteristics. Mod Pathol 9 (1996), 469–474.
22. 22 Arnaud, L., Haroche, J., Mathian, A., et al. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev 11 (2011), 61–67.
23. 23 Katsuyama, T., Sada, K.E., Makino, H., Current concept and epidemiology of systemic vasculitides. Allergol Int 63 (2014), 505–513.
24. 24 Brack, A., Geisler, A., Martinez-Taboada, V.M., et al. Giant cell vasculitis is a T cell–dependent disease. Mol Med 3 (1997), 530–543.
25. 25 Wagner, A.D., Björnsson, J., Bartley, G.B., et al. Interferon–gamma–producing T cells in giant cell vasculitis represent a minority of tissue–infiltrating cells and are located distant from the site of pathology. Am J Pathol 148 (1996), 1925–1933.
26. 26 Sneller, M.C., Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med 69 Suppl 2 (2002), SII40–SII43.
27. 27 Nityanand, S., Giscombe, R., Srivastava, S., et al. A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol 107 (1997), 261–268.
28. 28 Scott, D.G., Salmon, M., Scott, D.L., et al. Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?. Clin Rheumatol 5 (1986), 517–522.
29. 29 Seko, Y., Sato, O., Takagi, A., et al. Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation 93 (1996), 1788–1790.
30. 30 Deng, J., Younge, B.R., Olshen, R.A., et al. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121 (2010), 906–915.
31. 31 Wu, G., Mahajan, N., Dhawan, V., Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritis. Biomed Res Int, 2014, 2014, 827105.
32. 32 De Caridi, G., Massara, M., Spinelli, F., et al. Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia. Int Wound J, 2015, 10.1111/iwj.12464.
33. 33 Senzaki, H., The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 91 (2006), 847–851.
34. 34 Mahajan, N., Bisht, D., Dhawan, V., et al. Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura. Acta Paediatr 99 (2010), 1248–1252.
35. 35 Noris, M., Daina, E., Gamba, S., et al. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?. Circulation 100 (1999), 55–60.
36. 36 Tripathy, N.K., Sinha, N., Nityanand, S., Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. Clin Exp Rheumatol 22 (2004), S27–S30.
37. 37 Mahajan, N., Dhawan, V., Mahmood, S., et al. Extracellular matrix remodeling in Takayasu's arteritis: role of matrix metalloproteinases and adventitial inflammation. Arch Med Res 43 (2012), 406–410.
38. 38 Chauhan, S.K., Tripathy, N.K., Nityanand, S., Antigenic targets and pathogenicity of anti–aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum 54 (2006), 2326–2333.
39. 39 Chirinos, J.A., Corrales, V.F., Lichtstein, D.M., ANCA–associated large vessel compromise. Clin Rheumatol 25 (2005), 111–112.
40. 40 Misra, R., Aggarwal, A., Chag, M., et al. Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet 343 (1994), 1644–1645.
41. 41 Yokoi, K., Akaike, M., Shigekiyo, T., et al. An elderly patient with Takayasu's arteritis associated with antiphospholipid antibodies. Nippon Ronen Igakkai Zasshi 31 (1994), 716–719.
42. 42 Yokoi, K., Hosoi, E., Akaike, M., et al. Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology 47 (1996), 315–319.
43. 43 Nava, A., Senécal, J.L., Bañales, J.L., et al. Absence of antiphospholipid/co-factor antibodies in Takayasu arteritis. Int J Cardiol 75 Suppl 1 (2000), S99–S104.
44. 44 Wang, H., Ma, J., Wu, Q., et al. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. J Vasc Surg 53 (2011), 174–180.
45. 45 Uppal, S.S., Verma, S., Analysis of the clinical profile, autoimmune phenomena and T cell subsets (cd4 and cd8) in Takayasu's arteritis: a hospital–based study. Clin Exp Rheumatol 21 (2003), S112–S116.
46. 46 Tripathy, N.K., Sinha, N., Nityanand, S., Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 134 (2003), 360–364.
47. 47 Seko, Y., Sugishita, K., Sato, O., et al. Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 41 (2004), 84–90.
48. 48 Chauveau, A., Tonnerre, P., Pabois, A., et al. Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding. J Innate Immun 6 (2014), 89–104.
49. 49 Enomoto, S., Magara, J., Iwasaki, Y., et al. Aortitis syndrome in a pair of monozygotic twins. Nippon Naika Gakkai Zasshi 72 (1983), 1553–1556.
50. 50 Terao, C., Revisited HLA and non–HLA genetics of Takayasu arteritis-where are we?. J Hum Genet 61 (2016), 27–32.
51. 51 Dong, R.P., Kimura, A., Numano, F., et al. HLA–linked susceptibility and resistance to Takayasu arteritis. Heart Vessels Suppl 7 (1992), 73–80.
52. 52 Kasuya, K., Hashimoto, Y., Numenno, F., Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl 7 (1992), 116–119.
53. 53 Khraishi, M.M., Gladman, D.D., Dagenais, P., et al. HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum 35 (1992), 573–575.
54. 54 Soto, M.E., Vargas–Alarcón, G., Cicero–Sabido, R., et al. Comparison distribution of HLA–B alleles in mexican patients with takayasu arteritis and tuberculosis. Hum Immunol 68 (2007), 449–453.
55. 55 Matsumura, T., Amiya, E., Tamura, N., et al. A novel susceptibility locus for Takayasu arteritis in the IL12B region can be a genetic marker of disease severity. Heart Vessels 31 (2016), 1016–1019.
56. 56 Yagi, K., Kobayashi, J., Yasue, S., et al. Four unrelated cases with Takayasu arteritis and CD36 deficiency: possible link between these disorders. J Intern Med 255 (2004), 688–689.
57. 57 Saruhan–Direskeneli, G., Hughes, T., Aksu, K., et al. Identification of multiple genetic susceptibility Loci in takayasu arteritis. Am J Hum Genet 93 (2013), 298–305.
58. 58 Terao, C., Yoshifuji, H., Kimura, A., et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA–B regions in a Japanese population. Am J Hum Genet 93 (2013), 289–297.
59. 59 Renauer, P.A., Saruhan-Direskeneli, G., Coit, P., et al. Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study. Arthritis Rheumatol 67 (2015), 1361–1368.
60. 60 Sadurska, E., Jawniak, R., Majewski, M., et al. Takayasu arteritis as a cause of arterial hypertension. Case report and literature review. Eur J Pediatr 171 (2012), 863–869.
61. 61 Aggarwal, A., Chag, M., Sinha, N., et al. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol 55 (1996), 49–55.
62. 62 Kumar Chauhan, S., Kumar Tripathy, N., Sinha, N., et al. Cellular and humoral immune responses to mycobacterial heat shock protein–65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol 138 (2004), 547–553.
63. 63 Sano, K., (Trans.) Takayasu disease—pulseless disease Brain Nerve 60 (2008), 31–35.
64. 64 Uthman, I.W., Bizri, A.R., Hajj Ali, R.A., et al. Takayasu's arteritis presenting as fever of unknown origin: report of two cases and literature review. Semin Arthritis Rheum 28 (1999), 280–285.
65. 65 Rodriguez–Pla, A., Stone, H., Vasculitis and systemic infections. Curr Opin Rheumatol 18 (2006), 39–47.
66. 66 Brunner, J., Feldman, B.M., Tyrrell, P.N., et al. Takayasu arteritis in children and adolescents. Rheumatology (Oxford) 49 (2010), 1806–1814.
67. 67 Al abrawi, S., Fouillet–Desjonqueras, M., David, L., et al. Takayasu arteritis in children. Pediatr Rheumatol Online J, 6, 2008, 17.
68. 68 De Caridi, G., Butrico, L., Grande, R., et al. Concomitant aortic leiomyosarcoma and takayasu arteritis in a 55–year–old male patient. Ann Vasc Surg 28 (2014), 1931.e13–1931.e16.
69. 69 O'Connor, M.B., Murphy, E., O'Donovan, N., et al. Takayasu's Arteritis presenting as a dissecting aortic aneurysm history: a case report. Cases J, 21, 2008, 52.
70. 70 Zhang, Y., Zheng, J., Yang, P., et al. A case of Pickering syndrome caused by Takayasu arteritis: Manifestation, PTRA and 6-year follow up. Int J Cardiol 186 (2015), 39–40.
71. 71 Akar, S., Dogan, E., Goktay, Y., et al. Nasal septal perforation in a patient with Takayasu's arteritis; a rare association. Intern Med 48 (2009), 1551–1554.
72. 72 Ausaylah, B., Relapsing polychondritis in a patient with Takayasu disease; A rare association with fatal outcome. Rawal Med J 35 (2010), 108–110.
73. 73 Raza, K., Karokis, D., Kitas, G.D., Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 37 (1998), 369–372.
74. 74 Siglock, T.J., Brookler, K.H., Sensorineural hearing loss associated with Takayasu's disease. Laryngoscope 97 (1987), 797–800.
75. 75 Ishikawa, K., Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 12 (1988), 964–972.
76. 76 de Souza, A.W., de Carvalho, J.F., Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun 48-49 (2014), 79–83.
77. 77 Arend, W.P., Michel, B.A., Bloch, D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 (1990), 1129–1134.
78. 78 Sharma, B.K., Jain, S., Suri, S., et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54 Suppl (1996), S141–S147.
79. 79 Sharma, B.K., Siveski-Iliskovic, N., Singal, P.K., Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol 11 (1995), 311–316.
80. 80 Basu, N., Watts, R., Bajema, I., et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 69 (2010), 1744–1750.
81. 81 Craven, A., Robson, J., Ponte, C., et al. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS). Clin Exp Nephrol 17 (2013), 619–621.
82. 82 Ozen, S., Pistorio, A., Iusan, S.M., et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69 (2010), 798–806.
83. 83 Grayson, P.C., Maksimowicz-McKinnon, K., Clark, T.M., et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 71 (2012), 1329–1334.
84. 84 Arnaud, L., Haroche, J., Toledano, D., et al. Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arthritis Rheum 63 (2011), 1136–1140.
85. 85 Petrovic-Rackov, L., Pejnovic, N., Jevtic, M., et al. Longitudinal study of 16 patients with Takayasu's arteritis: clinical features and therapeutic management. Clin Rheumatol 28 (2009), 179–185.
86. 86 Moriwaki, R., Noda, M., Yajima, M., et al. Clinical manifestations of Takayasu arteritis in India and Japan—new classification of angiographic findings. Angiology 48 (1997), 369–379.
87. 87 Schmidt, W.A., Imaging in vasculitis. Best Pract Res Clin Rheumatol 27 (2013), 107–118.
88. 88 Yamada, I., Nakagawa, T., Himeno, Y., et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 209 (1998), 103–109.
89. 89 Pinheiro, L.W., LeBlang, S.D., Romano, J., et al. The acute diagnosis of Takayasu's arteritis based on helical CT angiography of the chest and neck in the emergency room. AJNR Am J Neuroradiol 20 (1999), 1983–1985.
90. 90 Hartlage, G.R., Palios, J., Barron, B.J., et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging 7 (2014), 605–619.
91. 91 Papa, M., De Cobelli, F., Baldissera, E., et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 198 (2012), W279–W284.
92. 92 Tso, E., Flamm, S.D., White, R.D., et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46 (2002), 1634–1642.
93. 93 Eshet, Y., Pauzner, R., Goitein, O., et al. The limited role of MRI in long-term follow-up of patients with Takayasu's arteritis. Autoimmun Rev 11 (2011), 132–136.
94. 94 Cheng, Y., Lv, N., Wang, Z., et al. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 31 (2013), S22–S27.
95. 95 Fuchs, M., Briel, M., Daikeler, T., et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 39 (2012), 344–353.
96. 96 Santhosh, S., Mittal, B.R., Gayana, S., et al. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol 21 (2014), 993–1000.
97. 97 Karapolat, I., Kalfa, M., Keser, G., et al. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol 31 (2013), S15–S21.
98. 98 Tezuka, D., Haraguchi, G., Ishihara, T., et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 5 (2012), 422–429.
99. 99 Arnaud, L., Haroche, J., Malek, Z., et al. Is 18F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in takayasu arteritis?. Arthritis Rheum 60 (2009), 1193–1200.
100. 100 Schmidt, W.A., Nerenheim, A., Seipelt, E., et al. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 41 (2002), 496–502.
101. 101 Kissin, E.Y., Merkel, P.A., Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 16 (2004), 31–37.
102. 102 Sun, Y., Yip, P.K., Jeng, J.S., et al. Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke 27 (1996), 2178–2182.
103. 103 Buckley, A., Southwood, T., Culham, G., et al. The role of ultrasound in evaluation of Takayasu's arteritis. J Rheumatol 18 (1991), 1073–1080.
104. 104 Alibaz-Oner, F., Direskeneli, H., Update on Takayasu's arteritis. Presse Med 44 (2015), e259–e265.
105. 105 Maksimowicz-McKinnon, K., Clark, T.M., Hoffman, G.S., Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?. Medicine (Baltimore) 88 (2009), 221–226.
106. 106 Furuta, S., Cousins, C., Chaudhry, A., et al. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?. J Rheumatol 42 (2015), 300–308.
107. 107 Gonzalez-Gay, M.A., Martinez-Dubois, C., Agudo, M., et al. Giant cell arteritis: epidemiology, diagnosis, and management. Curr Rheumatol Rep 12 (2010), 436–442.
108. 108 Al-Aghbari, K., Al-Motarreb, A., Askar, F., Takayasu's Arteritis Associated with Tuberculosis in a Young Yemeni Woman. Heart Views 11 (2010), 117–120.
109. 109 Pantell, R.H., Goodman, B.W. Jr., Takayasu's arteritis: the relationship with tuberculosis. Pediatrics 67 (1981), 84–88.
110. 110 Subramanyan, R., Joy, J., Balakrishnan, K.G., Natural history of aortoarteritis (Takayasu's disease). Circulation 80 (1989), 429–437.
111. 111 Heggtveit, H.A., Syphilitic aortitis. A clinicopathologic autopsy study of 100 cases, 1950 to 1960. Circulation 29 (1964), 346–355.
112. 112 Oz, M.C., Brener, B.J., Buda, J.A., et al. A ten-year experience with bacterial aortitis. J Vasc Surg 10 (1989), 439–449.
113. 113 Isobe, M., Takayasu arteritis revisited: current diagnosis and treatment. Int J Cardiol 168 (2013), 3–10.
114. 114 Phillip, R., Luqmani, R., Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 26 (2008), S94–S104.
115. 115 Maksimowicz–McKinnon, K., Clark, T.M., Hoffman, G.S., Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56 (2007), 1000–1009.
116. 116 Grayson, P.C., Cuthbertson, D., Carette, S., et al. New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol 40 (2013), 1905–1912.
117. 117 Ishikawa, K., Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 57 (1978), 27–35.
118. 118 Alibaz–Oner, F., Aydin, S.Z., Direskeneli, H., Advances in the diagnosis, assessment and outcome of Takayasu's arteritis. Clin Rheumatol 32 (2013), 541–546.
119. 119 Schmidt, J., Kermani, T.A., Bacani, A.K., et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 88 (2013), 822–830.
120. 120 Ohigashi, H., Haraguchi, G., Konishi, M., et al. Improved prognosis of Takayasu arteritis over the past decade – comprehensive analysis of 106 patients. Circ J 76 (2012), 1004–1011.
121. 121 Misra, R., Danda, D., Rajappa, S.M., et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 52 (2013), 1795–1801.
122. 122 Aydin, S.Z., Merkel, P.A., Direskeneli, H., Outcome measures for Takayasu's arteritis. Curr Opin Rheumatol 27 (2015), 32–37.
123. 123 Direskeneli, H., Aydin, S.Z., Merkel, P.A., Disease assessment in Takayasu's arteritis. Rheumatology (Oxford) 52 (2013), 1735–1736.
124. 124 Comarmond, C., Mirault, T., Biard, L., et al. Takayasu's arteritis and pregnancy. Arthritis Rheumatol 67 (2015), 3262–3269.
125. 125 Kötter, I., Henes, J.C., Wagner, A.D., et al. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Clin Exp Rheumatol 30 Suppl 70 (2012), S114–S129.
126. 126 Gasch, O., Vidaller, A., Pujol, R., Takayasu arteritis and pregnancy from the point of view of the internist. J Rheumatol 36 (2009), 1554–1555.
127. 127 Hoffman, G.S., Leavitt, R.Y., Kerr, G.S., et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37 (1994), 578–582.
128. 128 Valsakumar, A.K., Valappil, U.C., Jorapur, V., et al. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 30 (2003), 1793–1798.
129. 129 Shelhamer, J.H., Volkman, D.J., Parrillo, J.E., et al. Takayasu's arteritis and its therapy. Ann Intern Med 103 (1985), 121–126.
130. 130 Ozen, S., Duzova, A., Bakkaloglu, A., et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 150 (2007), 72–76.
131. 131 Goel, R., Danda, D., Mathew, J., et al. Mycophenolate mofetil in Takayasu's arteritis. Clin Rheumatol 29 (2010), 329–332.
132. 132 Shinjo, S.K., Pereira, R.M., Tizziani, V.A., et al. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol 26 (2007), 1871–1875.
133. 133 Yokoe, I., Haraoka, H., Harashima, H., A Patient with Takayasu's Arteritis and Rheumatoid Arthritis Who Responded to Tacrolimus Hydrate. Intern Med 46 (2007), 1873–1877.
134. 134 de Souza, A.W., da Silva, M.D., Machado, L.S., et al. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study. Scand J Rheumatol 41 (2012), 227–230.
135. 135 Tripathy, N.K., Gupta, P.C., Nityanand, S., High TNF-α and low IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol 118 (2006), 154–158.
136. 136 Schmidt, J., Kermani, T.A., Bacani, A.K., et al. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term follow-up. Arthritis Care Res (Hoboken) 64 (2012), 1079–1083.
137. 137 Comarmond, C., Plaisier, E., Dahan, K., et al. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature. Autoimmun Rev 11 (2012), 678–684.
138. 138 Hoyer, B.F., Mumtaz, I.M., Loddenkemper, K., et al. Takayasu arteritis is characterized by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab. Ann Rheum Dis 71 (2012), 75–79.
139. 139 Park, M.C., Lee, S.W., Park, Y.B., et al. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford) 45 (2006), 545–548.
140. 140 Osman, M., Emery, D., Yacyshyn, E., Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature. J Stroke Cerebrovasc Dis 24 (2015), 1291–1298.
141. 141 Mekinian, A., Comarmond, C., Resche-Rigon, M., et al. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter Retrospective Study of 49 Patients. Circulation 132 (2015), 1693–1700.
142. 142 Mason, J.C., Takayasu arteritis: surgical interventions. Curr Opin Rheumatol 27 (2015), 45–52.
143. 143 Keser, G., Direskeneli, H., Aksu, K., Management of Takayasu arteritis: a systematic review. Rheumatology (Oxford) 53 (2014), 793–801.
144. 144 Perera, A.H., Youngstein, T., Gibbs, R.G., et al. Optimizing the outcome of vascular intervention for Takayasu arteritis. Br J Surg 101 (2014), 43–50.
145. 145 Lee, B.B., Laredo, J., Neville, R., et al. Endovascular management of Takayasu arteritis: is it a durable option?. Vascular 17 (2009), 138–146.
146. 146 Min, P.K., Park, S., Jung, J.H., et al. Endovascular therapy combined with immunosuppressive treatment for occlusive arterial disease in patients with Takayasu's arteritis. J Endovasc Ther 12 (2005), 28–34.
147. 147 Qureshi, M.A., Martin, Z., Greenberg, R.K., Endovascular management of patients with Takayasu arteritis: stents versus stent grafts. Semin Vasc Surg 24 (2011), 44–52.
148. 148 Saadoun, D., Lambert, M., Mirault, T., et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis a multicenter experience. Circulation 125 (2012), 813–819.
149. 149 Miyata, T., The Asia Pacific meeting for vasculitis and ANCA workshop 2012: surgical treatment of Takayasu's arteritis. Clin Exp Nephrol 18 (2014), 296–300.
150. 150 Miyata, T., Sato, O., Koyama, H., et al. Long–term survival after surgical treatment of patients with Takayasu's arteritis. Circulation, 108, 2003, 1474.
151. 151 Li, C., Liu, Y., Qi, R., et al. Repair of aortic regurgitation due to Takayasu arteritis. Heart Surg Forum 16 (2013), E24–E26.
152. 152 Fields, C.E., Bower, T.C., Cooper, L.T., et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg 43 (2006), 64–71.
153. 153 Horie, N., Hayashi, K., Morikawa, M., et al. Restenosis after endovascular PTA/stenting for supra-aortic branches in Takayasu aortitis: report of three cases and review of the literature. Acta Neurochir (Wien) 153 (2011), 1135–1139 discussion 1139.
154. 154 Visonà, A., Tonello, D., Zalunardo, B., et al. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 7 (2009), 18–23.
155. 155 Tyagi, S., Verma, P.K., Gambhir, D.S., et al. Early and long–term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 21 (1998), 219–224.
156. 156 Ogino, H., Matsuda, H., Minatoya, K., et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 118 (2008), 2738–2747.
157. 157 Serra, R., Grande, R., Buffone, G., et al. Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis. J Pharmacol Pharmacother 5 (2014), 193–196.
158. 158 de Franciscis, S., Serra, R., Luongo, A., et al. The management of Takayasu's arteritis: personal experience. Ann Vasc Surg 21 (2007), 754–760.
159. 159 Prete, M., Indiveri, F., Perosa, F., Vasculitides: Proposal for an integrated nomenclature. Autoimmun Rev 15 (2016), 167–173.
160. 160 Robles, M., Reyes, P.A., Takayasu's arteritis in Mexico: a clinical review of 44 consecutive cases. Clin Exp Rheumatol 12 (1994), 381–388.
161. 161 Wilke, W.S., Large vessel vasculitis (giant cell arteritis, Takayasu arteritis). Baillieres Clin Rheumatol 11 (1997), 285–313.
162. 162 Wen, D., Du, X., Ma, C.S., Takayasu arteritis: diagnosis, treatment and prognosis. Int Rev Immunol 31 (2012), 462–473.
163. 163 Koide, K., Takayasu arteritis in Japan. Heart Vessels Suppl 7 (1992), 48–54.
164. 164 Toshihiko, N., Current status of large and small vessel vasculitis in Japan. Int J Cardiol 54 (1996), 91–98.
165. 165 Cid, M.C., Font, C., Coll-Vinent, B., et al. Large vessel vasculitides. Curr Opin Rheumatol 10 (1998), 18–28.
166. 166 Watts, R., Al-Taiar, A., Mooney, J., et al. The epidemiology of Takayasu arteritis in the UK. Rheumatology 48 (2009), 1008–1011.
167. 167 Waern, A.U., Andersson, P., Hemmingsson, A., Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology 34 (1983), 311–320.
168. 168 Mathew, A.J., Goel, R., Kumar, S., et al. Childhood-onset Takayasu arteritis: an update. Int J Rheum Dis 19 (2016), 116–126.
169. 169 Soliman, M., Laxer, R., Manson, D., et al. Imaging of systemic vasculitis in childhood. Pediatr Radiol 45 (2015), 1110–1125.
170. 170 Polachek, A., Pauzner, R., Levartovsky, D., et al. The fine line between Takayasu arteritis and giant cell arteritis. Clin Rheumatol 34 (2015), 721–727.
171. 171 Arnaud, L., Haroche, J., Limal, N., et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore) 89 (2010), 1–17.
172. 172 Tombetti, E., Di Chio, M.C., Sartorelli, S., et al. Anti-cytokine treatment for Takayasu arteritis: State of the art. Intractable Rare Dis Res 3 (2014), 29–33.
173. 173 Youngstein, T., Peters, J., Hamdulay, S.S., et al. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis. Clin Exp Rheumatol 32 (2014), S11–S18.